Journal
RENAL FAILURE
Volume 39, Issue 1, Pages 474-483Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/0886022X.2017.1313164
Keywords
Podocyte; epithelial-mesenchymal transition; molecular mechanism; diabetic kidney isease; hyperglycemia
Categories
Ask authors/readers for more resources
Epithelial-mesenchymal transition (EMT) is a tightly regulated process by which epithelial cells lose their hallmark epithelial characteristics and gain the features of mesenchymal cells. For podocytes, expression of nephrin, podocin, P-cadherin, and ZO-1 is downregulated, the slit diaphragm (SD) will be altered, and the actin cytoskeleton will be rearranged. Diabetes, especially hyperglycemia, has been demonstrated to incite podocyte EMT through several molecular mechanisms such as TGF-b/Smad classic pathway, Wnt/b-catenin signaling pathway, Integrins/integrin-linked kinase (ILK) signaling pathway, MAPKs signaling pathway, Jagged/Notch signaling pathway, and NF-kappa B signaling pathway. As one of the most fundamental prerequisites to develop groundbreaking therapeutic options to prevent the development and progression of diabetic kidney disease (DKD), a comprehensive understanding of the molecular mechanisms involved in the pathogenesis of podocyte EMT is compulsory. Therefore, the purpose of this paper is to update the research progress of these underlying signaling pathways and expound the podocyte EMT-related DKDs.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available